NCT06666504View on ClinicalTrials.gov

The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

June 30, 2026

Conditions
Severe Asthma
Interventions
OTHER

Combined Retrospective and Prospective Data Analysis

Collection of both retrospective and prospective data all ready available for participant

Trial Locations (1)

SE1 7EH

Guys & St Thomas NHS Foundation Trust, London

All Listed Sponsors
collaborator

King's College London

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT06666504 - The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study | Biotech Hunter | Biotech Hunter